End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age von Castellsagué, X, Muñoz, N, Pitisuttithum, P, Ferris, D, Monsonego, J, Ault, K, Luna, J, Myers, E, Mallary, S, Bautista, O M, Bryan, J, Vuocolo, S, Haupt, R M, Saah, A

Volltext

The new challenges in the prevention of cervical cancer von Monsonego, J

Volltext

EUROGIN 2007 roadmap on cervical cancer prevention von Monsonego, J

Volltext

HPV infections and cervical cancer prevention. Priorities and new directions. Highlights of EUROGIN 2004 International Expert Meeting, Nice, France, October 21–23, 2004 von Monsonego, J.

Volltext

Relative prevalence of high risk HPV genotypes in a US population: Insights before rollout of the next generation 9-valent HPV vaccine von Behrens, C.M, Monsonego, J, Cox, T, Sandri, M.T, Yap, P.S, Franco, E.L

Volltext

HPV testing and cervical cancer screening. Evidences, resistances and current practices von Monsonego, J

Volltext

EUROGIN 2010: roadmap on cervical cancer prevention von Monsonego, J

Volltext

New prevention strategies of HPV infection and cervical cancer von Monsonego, J.

Volltext

EUROGIN 2010 : feuille de route pour la prévention du cancer du col de l’utérus von Monsonego, J.

Volltext

Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine von Monsonego, J, Cortes, J, Greppe, C, Hampl, M, Joura, E, Singer, A

Volltext

Current direction in the prevention of cervical cancer von Monsonego, J

Volltext

Cervical Cancer Prevention – Current Perspectives von Monsonego, J.

Volltext

Corrigendum to “Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine” [Vaccine 28 (2010) 8065–8072]... von Monsonego, J, Cortes, J, Greppe, C, Hampl, M, Joura, E, Singer, A

Volltext

Liquid-based cytology for primary cervical cancer screening: a multi-centre study von Monsonego, J, Autillo-Touati, A, Bergeron, C, Dachez, R, Liaras, J, Saurel, J, Zerat, L, Chatelain, P, Mottot, C

Volltext

O632 Results of the French APTIMA HPV screening evaluation (FASE Study) von Monsonego, J., Halfon, P., Zerat, L., Ricart, M., Zerat, J.

Volltext

Prevention of cervical cancer (II): Prophylactic HPV vaccination, current knowledge, practical procedures and new issues von Monsonego, J

Volltext

Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions von Dockter, Janel, Schroder, Astrid, Hill, Craig, Guzenski, Leah, Monsonego, Joseph, Giachetti, Cristina

Volltext

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment von CAPEAU, Jacqueline, BOUTELOUP, Vincent, KATLAMA, Christine, BASTARD, Jean-Philippe, GUIYEDI, Vincent, SALMON-CERON, Dominique, PROTOPOPESCU, Camelia, LEPORT, Catherine, RAFFI, Francois, CHENE, Genevieve

Volltext

Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia von MONSONEGO, J., PINTOS, J., SEMAILLE, C., BEUMONT, M., DACHEZ, R., ZERAT, L., BIANCHI, A., FRANCO, E.

Volltext

Métaplasie et CIN de haut grade. Difficultés diagnostiques: P. Tranbaloc Gynécol Obstét Fertil 2002; 30: 845-849 von Monsonego, J

Volltext